Clinical Trial Protocol: A Randomized Phase 2 Trial of FLEXible and Extended Dosing of 177Lu-Psma-617 Molecular Radioligand Therapy (FLEX-MRT)
JOURNAL OF NUCLEAR MEDICINE(2024)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined